Schizophrenia, which affects 1 out of 100 persons in the world, causes great suffering for patients and their families. To this day, no treatment allows to improve all of the disabling symptoms related to the disease. However, research has achieved considerable progress, leading to new therapeutic perspectives and, in the longer term, possible measures to prevent schizophrenia.
Public funds cover approximately half of the research costs – the other half has to be provided through the support of private donors. Despite the important and recognized prevalence of schizophrenia and other psychiatric diseases, the financing of research in this field remains a major challenge and falls a long way behind the means invested for the benefit of somatic medicine. Ignorance of the massive scale of schizophrenia as well as the clichés, taboos and fear still linked to psychiatric diseases hinder a broader public awareness, needed to advance research, and represent additional obstacles to scientific and therapeutic progress.
The goal of the Alamaya Foundation is to collect private funds needed to advance research – and thus to bring back hope to those who are faced with this devastating disorder.
“Je souffre d’une effroyable maladie de l’esprit, d’un effondrement central de l’âme… ma pensée m’abandonne…”
“I suffer from a dreadful disease of the mind, a central collapse of the soul… my thoughts are abandoning me…”
“Il y a une angoisse acide et trouble, aussi puissante qu’un couteau, et dont l’écartèlement a le poids de la terre…”
“There is a sharp and blurred anguish, as powerful as a knife, which tears me apart…”
actor and director (1896-1948)